$49.32
▲ +0.0% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead
Overview
52-week range
$31
$55
76% of range
Avg surprise (last 2)
+9.5%
Avg reaction (last 1)
-4.0%
0% positive
Latest IV / EM
52%
EM ±8.1% · $50 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.77 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.09 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $1.15 | $1.13 | +1.8% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $0.95 | $0.81 | +17.3% | — | -4.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.57 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.96 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.63 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.50 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.43 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.06 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $1.48 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $343M | — | $338M | $342M | $321M | — | $317M | $332M |
| Cost of revenue | $146M | — | $172M | $154M | $144M | — | $138M | $148M |
| Gross profit | $197M | — | $166M | $188M | $178M | — | $179M | $184M |
| Operating income | $36M | — | $12M | $38M | $16M | — | $66M | $47M |
| Net income | $23M | — | $3M | $21M | $6M | — | $49M | $30M |
| EPS (diluted) | $0.77 | — | $0.09 | $0.69 | $0.19 | — | $1.57 | $0.96 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $360M | $356M | $364M | $362M | $355M | $347M | $343M | $322M |
| Total current assets | $676M | $673M | $662M | $658M | $639M | $640M | $641M | $624M |
| Total assets | $2.30B | $2.33B | $2.32B | $2.33B | $2.30B | $2.31B | $2.32B | $2.29B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1.26B | $1.29B | $1.31B | $1.33B | $1.32B | $1.34B | $1.38B | $1.40B |
| Total equity | $1.04B | $1.03B | $1.01B | $1.00B | $978M | $963M | $933M | $882M |